biologics
| 7 min read
Nanosyringes produced by some bacterial species naturally inject proteins into eukaryotic cells, paving a new frontier for biologic drug delivery.
Available on Demand
LIVE April 19th, 2022 at 11:30 AM
Biologics targeting coronavirus and variants of interest emerge as the latest therapeutic strategy for treating COVID-19.
Biologics targeting coronavirus and variants of interest emerge as the latest therapeutic strategy for treating COVID-19.
| 10+ min read
A hormone only discussed among specialized scientists is making a big splash in the ovarian health field. It may soon become a household name.
| 4 min read
Scientists engineer the photosynthetic bacteria spirulina to produce biologics at a large enough scale to treat some of the world’s deadliest and most prevalent diseases.
| 10+ min read
Small antibodies called nanobodies produced in camels, llamas, and alpacas might help stop the spread of COVID-19, but can they stand up against the competition?
| 3 min read
New collaborations will give I-Mab access to cutting edge technology platforms for developing novel drug molecules
| 3 min read
Clinical trial data demonstrate potential for BD Libertas wearable drug delivery system
| 3 min read
Data show full complement ST266 biologic offers better neuroprotection than fractionated formats
